On its own, obesity can cause acute ailments, including breathlessness and back pain. Worse, it often leads to other chronic ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 496.78% and ...

Novo Nordisk is investing more than $1 billion in a new production facility in Denmark. Elsewhere, drugs from Neurocrine ...

The Danish Medicines Agency said it would ask European authorities to review two new studies that point to a link between ...

Novo’s latest investment comes just days after the U.S. FTC greenlit the highly contentious acquisition of Catalent, which ...

The Danish Medicines Agency had been watching reports of a rare eye disease in patients who took Novo’s GLP-1 drug but until ...

After clearing all regulatory hurdles associated with its proposed buyout of CDMO Catalent, Novo Holdings is nearly ready to ...

Novo Nordisk (NVO) is making headlines with its inventive investment of $1.2 billion aimed at building a new production ...

Investors' focus could, however, shift back onto the possible market impacts of GLP-1 agonists in 2025, particularly as a result of a major expansion of current supplies after Novo Nordisk was given a ...

Danish health authorities said on Monday they would ask the European Union's drug regulator to review the findings of two ...

Danish studies have found a potential link between the diabetes drug Ozempic and a rare eye condition called non-arteritic ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.